Literature DB >> 32052478

TCR-α/β CD4- CD8- double negative T cells arise from CD8+ T cells.

Noé Rodríguez-Rodríguez1,2,3, Giovanna Flores-Mendoza2, Sokratis A Apostolidis1,4, Florencia Rosetti2, George C Tsokos1, José C Crispín1,2,5.   

Abstract

The cellular origin of CD4- CD8- (double negative, DNT) TCR-α/β+ T cells remains unknown. Available evidence indicates that they may derive from CD8+ T cells, but most published data have been obtained using cells that bear an invariant transgenic T cell receptor that recognizes an Ag that is not present in normal mice. Here, we have used complementary fate mapping and adoptive transfer experiments to identify the cellular lineage of origin of DNT cells in wild-type mice with a polyclonal T cell repertoire. We show that TCR-α/β+ DNT cells can be traced back to CD8+ and CD4+ CD8+ double positive cells in the thymus. We also demonstrate that polyclonal DNT cells generated in secondary lymphoid organs proliferate upon adoptive transfer and can regain CD8 expression in lymphopenic environment. These results demonstrate the cellular origin of DNT cells and provide a conceptual framework to understand their presence in pathological circumstances. ©2020 Society for Leukocyte Biology.

Entities:  

Keywords:  CD8 T cell; double-negative T cell; peripheral tolerance

Mesh:

Substances:

Year:  2020        PMID: 32052478      PMCID: PMC8118277          DOI: 10.1002/JLB.1AB0120-548R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  31 in total

1.  Double-negative T regulatory cells can develop outside the thymus and do not mature from CD8+ T cell precursors.

Authors:  Megan S Ford; Zhu-Xu Zhang; Wenhao Chen; Li Zhang
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

2.  Thymic precursors of TCRαβ(+)CD8αα(+) intraepithelial lymphocytes are negative for CD103.

Authors:  Xianghua Guo; Yuriko Tanaka; Motonari Kondo
Journal:  Immunol Lett       Date:  2014-11-22       Impact factor: 3.685

3.  Elevated T cell receptor signaling identifies a thymic precursor to the TCRαβ(+)CD4(-)CD8β(-) intraepithelial lymphocyte lineage.

Authors:  Benjamin D McDonald; Jeffrey J Bunker; Isabel E Ishizuka; Bana Jabri; Albert Bendelac
Journal:  Immunity       Date:  2014-08-14       Impact factor: 31.745

4.  CD4-CD8- thymocytes that express the T cell receptor may have previously expressed CD8.

Authors:  L Wu; M Pearse; M Egerton; H Petrie; R Scollay
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

5.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

6.  Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome.

Authors:  Shigui Zhu; Amy P Hsu; Marla M Vacek; Lixin Zheng; Alejandro A Schäffer; Janet K Dale; Joie Davis; Roxanne E Fischer; Stephen E Straus; Donna Boruchov; Frank T Saulsbury; Michael J Lenardo; Jennifer M Puck
Journal:  Hum Genet       Date:  2006-01-31       Impact factor: 4.132

7.  CD2-CD4-CD8- lymph node T lymphocytes in MRL lpr/lpr mice are derived from a CD2+CD4+CD8+ thymic precursor.

Authors:  M M Landolfi; N Van Houten; J Q Russell; R Scollay; J R Parnes; R C Budd
Journal:  J Immunol       Date:  1993-07-15       Impact factor: 5.422

8.  Human TCR alpha/beta+ CD4-CD8- double-negative T cells in patients with autoimmune lymphoproliferative syndrome express restricted Vbeta TCR diversity and are clonally related to CD8+ T cells.

Authors:  Anne Bristeau-Leprince; Véronique Mateo; Annick Lim; Aude Magerus-Chatinet; Eric Solary; Alain Fischer; Frédéric Rieux-Laucat; Marie-Lise Gougeon
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

9.  Human TCR-alpha beta+ CD4- CD8- T cells can derive from CD8+ T cells and display an inflammatory effector phenotype.

Authors:  José C Crispín; George C Tsokos
Journal:  J Immunol       Date:  2009-09-04       Impact factor: 5.422

10.  CD8αα intraepithelial lymphocytes arise from two main thymic precursors.

Authors:  Roland Ruscher; Rebecca L Kummer; You Jeong Lee; Stephen C Jameson; Kristin A Hogquist
Journal:  Nat Immunol       Date:  2017-05-22       Impact factor: 25.606

View more
  7 in total

Review 1.  TCRαβ+ CD4-/CD8- "double negative" T cells in health and disease-implications for the kidney.

Authors:  Andrea M Newman-Rivera; Johanna T Kurzhagen; Hamid Rabb
Journal:  Kidney Int       Date:  2022-04-09       Impact factor: 18.998

2.  Fas/FasL Signaling Regulates CD8 Expression During Exposure to Self-Antigens.

Authors:  Giovanna Flores-Mendoza; Noé Rodríguez-Rodríguez; Rosa M Rubio; Iris K Madera-Salcedo; Florencia Rosetti; José C Crispín
Journal:  Front Immunol       Date:  2021-03-24       Impact factor: 7.561

Review 3.  CD3+CD4-CD8- (Double-Negative) T Cells in Inflammation, Immune Disorders and Cancer.

Authors:  Zhiheng Wu; Yu Zheng; Jin Sheng; Yicheng Han; Yanyan Yang; Hongming Pan; Junlin Yao
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

Review 4.  Application of double-negative T cells in haematological malignancies: recent progress and future directions.

Authors:  Xingchi Chen; Dongyao Wang; Xiaoyu Zhu
Journal:  Biomark Res       Date:  2022-03-14

5.  Helios Expression Is Downregulated on CD8+ Treg in Two Mouse Models of Lupus During Disease Progression.

Authors:  Andrés París-Muñoz; Gonzalo Aizpurua; Domingo F Barber
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

6.  Splicing factor SRSF1 is essential for CD8 T cell function and host antigen-specific viral immunity.

Authors:  Ignacio Juarez; Shi Su; Zachary T Herbert; John R Teijaro; Vaishali R Moulton
Journal:  Front Immunol       Date:  2022-09-16       Impact factor: 8.786

Review 7.  Double-negative T cells in autoimmune diseases.

Authors:  Hao Li; George C Tsokos
Journal:  Curr Opin Rheumatol       Date:  2021-03-01       Impact factor: 4.941

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.